Free plasmids for September come from Dr. Changhao Bi’s new Glycosylase Base Editors. The BES could cause C-to-A transversions in Escherichia coli and C-to-G transversions in mammalian cells.
In this webcast, Dr. Samantha Zaroff of GenScript and Dr. Julie Rumble of Cayman Chemical will review the use of neoantigen peptides in personalized cancer treatment and share techniques for predicting and producing difficult neoantigen peptides.
